ACH is caused by activating mutations in the fibroblast growth factor receptor 3 (FGFR3) gene, which is a negative regulator of longitudinal bone growth (Rousseau et al., 1994; Shiang et al., 1994). The gene discussed is FGFR3; the disease is achondroplasia.